Abstract: In one example, a semiconductor device can comprise a substrate, a device stack, first and second internal interconnects, and an encapsulant. The substrate can comprise a first and second substrate sides opposite each other, a substrate outer sidewall between the first substrate side and the second substrate side, and a substrate inner sidewall defining a cavity between the first substrate side and the second substrate side. The device stack can be in the cavity and can comprise a first electronic device, and a second electronic device stacked on the first electronic device. The first internal interconnect can be coupled to the substrate and the device stack. The encapsulant can cover the substrate inner sidewall and the device stack and can fill the cavity. Other examples and related methods are disclosed herein.

Abstract: Disclosed is a cushion tip-up type seat for a vehicle. The cushion tip-up type seat for a vehicle is configured to perform a tip-up function of a cushion part, and to move a seat leftward and rightward to adjust an interval between left and right seats, whereby left and right spacing between occupants seated in the seats is sufficiently secured and the convenience of the occupants is improved.

Abstract: The present invention relates to a heteroaryl derivative compound and a use thereof. Since the heteroaryl derivative of the present invention exhibits excellent inhibitory activity against EGFR, the heteroaryl derivative can be usefully used as a therapeutic agent for EGFR-associated diseases.

Abstract: A quad-polarized antenna system according to the present invention comprises a plurality of RF chains, and an antenna array in which rows of first dual-polarized antenna units and rows of second dual-polarized antenna units are alternately arranged in a horizontal direction. The first dual-polarized antenna unit and the second dual-polarized antenna unit have different dual polarization characteristics from each other. The rows of first dual-polarized antenna units are used to form at least one first beam and at least one second beam which have +/?45° polarizations, and the rows of second dual-polarized antenna units are used to form at least one third beam and at least one fourth beam which have 0°/90° polarizations. The first beam, the second beam, the third beam, and the fourth beam are formed towards different spatial directions, and the first and third beams correspond to main lobes, and the second and fourth beams correspond to grating lobes.

Abstract: An antenna device is provided. The antenna device includes a base; an antenna group including a plurality of radiating elements disposed on the base along a first direction; and a feed line configured to feed power to the plurality of radiating elements, the feed line having an air-strip structure, wherein the feed line includes: a plurality of connection line regions configured such that one end is connected to each radiating element of the plurality of radiating elements, and a main line region bent at a predetermined angle at the other end of the connection line region and formed along the first direction from a side surface of the antenna group.

Abstract: The pharmaceutical composition according to the present invention contains the active ingredient dimethyl fumarate or monomethyl fumarate or a pharmaceutically acceptable salt thereof in a specific dose, and exhibits specific pharmacokinetic parameters when administered into the body. In addition, the pharmaceutical composition of the present invention has proven its efficacy and safety in type 2 diabetic nephropathy patients with albuminuria, and thus can be effectively used as a preventive or therapeutic agent for diabetic nephropathy.

Abstract: The present invention relates to a preparation method of a novel vascular leakage blocker with a high yield. The preparation method is easy to react and more productive and economical than the conventional method by using an intermediate that can easily remove impurities generated during the reaction. In addition, the preparation method can produce a novel vascular leakage blocker with a high yield by using a new reagent that has not been previously used in the step of generating an isomer, and is very advantageous in producing a high-quality active pharmaceutical ingredient.

Abstract: The present invention relates to a crystalline form Of (E)-methyl 6-((3S,8S,9S,10R,13S,14S,17R)-3-(((5S,6R)-5-acetoxy -6-(acetoxytnethyl)-5,6-dihydro-2H-pyran-2-yl)oxy)-10,13 -dimethyl-2,3,4,7,8,9,10.11,12,13,14,15,16,17-tetradecahydro -1H-cyclopenta [a]phenanthrene-17-yl)hept-5-enoate and a blood vessel leak blocker comprising the same. The novel crystalline form has high purity, excellent stability, excellent long-term storage and pharmaceutical stability, and can be used as a vascular leakage blocker, so it is very advantageous in producing high-quality drug substances.

Abstract: The present invention relates to a novel tryptophan hydroxylase inhibitor and a pharmaceutical composition including same, wherein the novel tryptophan hydroxylase inhibitor has an excellent inhibitory effect on TPH1, and thus can be usefully used for the prevention or treatment of disorders, such as metabolic disorders, cancer, digestive or cardiovascular system disorders, related to TPH1 activity. In particular, the novel tryptophan hydroxylase inhibitor has an excellent treatment effect on inflammatory bowel disorders, and thus can be usefully used for the treatment of inflammatory bowel disorder.

Abstract: The present invention relates to a cancer immunotherapy adjuvant, wherein the adjuvant, when administered in combination with a cancer immunotherapy agent, activates the function of immune factors without causing in vivo side effects, to exhibit the effect of enhancing the kit for anticancer effect of the cancer immunotherapy agent, and thus can be effectively used as a cancer immunotherapy adjuvant.

Abstract: The present invention relates to an enteric coating tablet comprising: a core containing, as an active ingredient, dimethyl fumarate or a pharmaceutically acceptable salt thereof; and an enteric coating layer, and provides a tablet, which exhibits an effect equal to that of a capsule dosage form currently on the market, can be prepared through a simple preparation process, and is a dosage form having excellent storage stability and administration convenience, and thus can be applied to various patient groups.

Abstract: The present invention relates to a preparation method of a novel vascular leakage blocker with a high yield. The preparation method is easy to react and more productive and economical than the conventional method by using an intermediate that can easily remove impurities generated during the reaction. In addition, the preparation method can produce a novel vascular leakage blocker with a high yield by using a new reagent that has not been previously used in the step of generating an isomer, and is very advantageous in producing a high-quality active pharmaceutical ingredient.

Abstract: The present invention relates to a novel tryptophan hydroxylase inhibitor and a pharmaceutical composition including same, wherein the novel tryptophan hydroxylase inhibitor has an excellent inhibitory effect on TPH1, and thus can be usefully used for the prevention or treatment of disorders, such as metabolic disorders, cancer, digestive or cardiovascular system disorders, related to TPH1 activity. In particular, the novel tryptophan hydroxylase inhibitor has an excellent treatment effect on inflammatory bowel disorders, and thus can be usefully used for the treatment of inflammatory bowel disorder.

Abstract: The present disclosure relates to novel fluoromonomer and fluorooligomer compounds, a photopolymerizable composition including these compounds, methods for producing these compounds, and a hydrophobic film using the photopolymerizable composition.

Abstract: The present disclosure provides a polarized antenna including a waveguide power divider, a waveguide phase shifter and a radiating unit. The waveguide power divider is configured to have an input waveguide for receiving a transmission signal, and first and second output waveguides for distributing and outputting the transmission signal. The waveguide phase shifter is configured to receive two output signals outputted respectively from the first and second output waveguides of the waveguide power divider, to variably change a phase difference between the two input signals, and to output respective changed signals. The radiating unit is configured to receive the respective changed signals from the waveguide phase shifter, and to combine and radiate the respective changed signals as a radio signal.

Abstract: The present invention relates to a lipid nanomaterial containing lysophosphatidylcholine or an ether derivative thereof, a method for preparing the same, a method for reducing erythrocyteolysis and hemagglutination using the compound, and a pharmaceutical agent containing the lipid nanomaterial. The present invention contains lysophosphatidylcholine or an ether derivative thereof as an active ingredient, and can be useful as a treatment agent for septicemia, bacterial infection diseases, and the like.

Abstract: The present disclosure relates to novel fluoromonomer and fluorooligomer compounds, a photopolymerizable composition including these compounds, methods for producing these compounds, and a hydrophobic film using the photopolymerizable composition.

Abstract: The present invention relates to a composition and health functional food for inhibiting apoptosis of cranial nerve cells, and to a method for inhibiting apoptosis, wherein the composition and health functional food comprising a phosphodiesterase type 5 active inhibitor. According to the present invention, the PDE5 inhibitor exhibits a protective effect on nerve cells by inhibiting apoptosis of cranial nerve cells. Thus, the present invention can be effectively used to prevent, alleviate, and treat cranial nerve disease.

Abstract: The present disclosure provides a polarized antenna including a waveguide power divider, a waveguide phase shifter and a radiating unit. The waveguide power divider is configured to have an input waveguide for receiving a transmission signal, and first and second output waveguides for distributing and outputting the transmission signal. The waveguide phase shifter is configured to receive two output signals outputted respectively from the first and second output waveguides of the waveguide power divider, to variably change a phase difference between the two input signals, and to output respective changed signals. The radiating unit is configured to receive the respective changed signals from the waveguide phase shifter, and to combine and radiate the respective changed signals as a radio signal.

Abstract: The present invention relates to a composition and health functional food for inhibiting apoptosis of cranial nerve cells, and to a method for inhibiting apoptosis, wherein the composition and health functional food comprising a phosphodiesterase type 5 active inhibitor. According to the present invention, the PDE5 inhibitor exhibits a protective effect on nerve cells by inhibiting apoptosis of cranial nerve cells. Thus, the present invention can be effectively used to prevent, alleviate, and treat cranial nerve disease.